US Stock Futures Flat Ahead Of ADP Jobs Report
US stock futures traded mostly flat in early pre-market trading, ahead of economic data. The ADP national employment report for February will be released at 8:15 a.m. ET. The Markit PMI services index for February will be released at 8:58 a.m. ET, while the ISM non-manufacturing index for February will be released at 10:00 a.m. ET. The Federal Open Market Committee will release its latest Beige Book report at 2:00 p.m. ET. Futures for the Dow Jones Industrial Average gained 6 points to 16,387.00, while the Standard & Poor's 500 index futures rose 0.70 points to 1,872.30. Futures for the Nasdaq 100 index surged 2.50 points to 3,719.25.
A Peek Into Global Markets
European markets were mostly lower today, with the Spanish Ibex Index rising 0.13%, London's FTSE 100 index dropping 0.52% and STOXX Europe 600 Index declining 0.19%. German DAX 30 index fell 0.38% and French CAC 40 Index declined 0.37%. Euro-zone composite PMI surged to 53.3 in February versus 52.9 in January.
Asian markets ended mixed today. Japan's Nikkei Stock Average gained 1.20%, Hong Kong's Hang Seng Index fell 0.34%, China's Shanghai Composite Index fell 0.89% and India's BSE Index jumped 0.12%. The HSBC China services PMI climbed to 51.0 in February versus 50.7 in January.
Analysts at Credit Suisse downgraded Dillard's (NYSE: DDS) from “outperform” to “neutral.” The price target for Dillard's is set to $93.
Dillard's shares closed at $91.27 yesterday.
- AeroVironment (NASDAQ: AVAV) shares jumped more than six percent in after hours trading after the company announced its third quarter results. The firm reported a Q3 EPS of $0.49 versus the Street estimate of $0.19. Earnings per share were up 188 percent from the year-ago period. To read the full news, click here.
- Ceres (NASDAQ: CERE) announced today the pricing of an underwritten public offering of 20,000,000 shares of common stock at a public offering price of $1.00 per share. To read the full news, click here.
- USEC (NYSE: USU) announced today that it is implementing the agreement reached with a majority of the holders of its senior unsecured convertible notes that was announced in December 2013. To read the full news, click here.
- Eisai (OTC: ESALF) and Biogen Idec (NASDAQ: BIIB) announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401. To read the full news, click here.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.